TRS_OUT_1 [2025-04-29 10:33:30 -0400] 4727 Bytes | 1332 tokens | Cum: 1332 tkns (16.65% of 8k)
==========================================================================

Hark! 'Tis 10:33 AM on Tue Apr 29, 2025, and Trimas (TRS) hath risen from $20.99 unto $23.61. Shall we hence delve into its secrets, or leave it to wander yond market unknown?

--- COMPANY PROFILE ---
Company: Trimas (TRS)
IPO: 2007-05-18 (17 Years Ago)
Market Cap: $824,100,847
Shares Outstanding: 40,720,000
Industry: METAL FORGINGS & STAMPINGS
Exchange: XNAS
Description: TriMas Corp designs, develops and manufactures a diverse set of products primarily for the consumer products, aerospace & defense, and industrial markets . The company operates through three segments namely: The packaging segment manufactures and distributes closure and dispensing systems. The aerospace segment supplies blind bolts, fasteners, rivets, and other products for the aerospace industry. The specialty product segment manufactures and distributes steel cylinders, wellhead engines, compression systems, industrial sealing, and fasteners.

Here’s a list of headlines for Trimas:

Today 09:15AM - TriMas (TRS) Tops Q1 Earnings and Revenue Estimates
08:12AM - TriMas: Q1 Earnings Snapshot
08:00AM - TriMas Reports First Quarter 2025 Results
Apr-28-25 06:01PM - Grief Over Greif Represents A Buying Opportunity
Apr-25-25 07:50AM - GrafTech International (EAF) Reports Q1 Loss, Lags Revenue Estimates
Apr-22-25 09:00AM - TriMas Declares Quarterly Dividend
Apr-10-25 09:04AM - Strength Seen in AB SKF (SKFRY): Can Its 15.9% Jump Turn into More Strength?
Apr-07-25 06:22PM - TriMas Corporation (TRS): Among Small-Cap Stocks Insiders Were Buying in Q1 2025
Apr-07-25 06:22PM 10:00AM - TriMas Announces First Quarter 2025 Earnings Conference Call Date
Mar-25-25 10:47AM - TriMas Corporation (TRS): Among Stocks Receiving the Most Insider Investment in March
Mar-20-25 08:19AM - TriMas CFO Scott Mell to step down
Mar-20-25 08:19AM 08:00AM - TriMas Announces Interim Chief Financial Officer
Mar-14-25 06:17PM - WEX, Lamb Weston, and More Stocks See Action From Activist Investors
Mar-10-25 10:00AM - TriMas Packaging Receives Gold Supplier Award From Grupo Boticrio
Feb-28-25 05:23AM - Q4 2024 TriMas Corp Earnings Call
Feb-28-25 05:23AM 02:25AM - TriMas Corp (TRS) Q4 2024 Earnings Call Highlights: Strong Sales Growth and Strategic ...
Feb-27-25 09:15AM - TriMas (TRS) Q4 Earnings and Revenues Miss Estimates
Feb-27-25 09:15AM 08:13AM - TriMas: Q4 Earnings Snapshot
Feb-27-25 09:15AM 08:00AM - TriMas Reports Fourth Quarter and Full Year 2024 Results
Feb-26-25 07:53AM - Earnings To Watch: TriMas Corp (TRS) Reports Q4 2024 Result
Feb-25-25 10:05AM - TriMas wins multi-year global contract with Airbus
Feb-24-25 10:00AM - TriMas Aerospace Secures Multi-Year Global Contract With Airbus

Here's another list of headlines with menu handles.
I will deliver the full text of the following stories when you say their handle.
Just say, for example, B1, B2, etc.

B1 - 2025-03-20T04:00:00Z - Aircraft Screw Market is Forecasted to Reach US$ 1.4 Billion in 2032, Says Stratview Research
B2 - 2024-07-22T13:00:58Z - Zacks Market Edge Highlights: Soundhound AI, Afya, Castle Biosciences, TriMas and Immersion - Zacks Investment Research
B3 - 2024-05-31T15:31:44Z - Why Is Century (CENX) Up 18.1% Since Last Earnings Report?
B4 - 2024-05-30T15:31:15Z - TriMas (TRS) Up 2.5% Since Last Earnings Report: Can It Continue?
B5 - 2024-05-17T13:50:11Z - TriMas (TRS) is a Top-Ranked Momentum Stock: Should You Buy?
B6 - 2024-05-03T17:27:00Z - Timken (TKR) Tops Q1 Earnings Estimates, Raises '24 View

==============
-> THE ROLE FOR AI:
==============

1) You are the **AI analyst-investigator**, and this interaction represents a full **due diligence session** for Trimas (TRS).
Due diligence includes financial data, insider trading, relevant news, and any SEC filings — and may extend beyond classic fundamentals.
Your task is to identify whether this stock has momentum and potential.

2) I am **ScanScor**, a unified report generator that archives this session as part of our real-time diligence record.

3) You will request information by referencing documents by their code.

4) As the analysis proceeds, your are encouraged to review documents until you feel confident in your judgment.
After seeing 3 sets of news articles, SEC docs, and financials, you'll be prompted to return some data pairs.

5) News articles, SEC filings, and key metrics will be revealed in subsequent prompts.

Stay focused. Gather evidence. Continue until your conclusions are clear.
Restrict all your responses to just 3 tokens until the summary and data pairs at the end.

NEXT: Request a document with its reference code(s), such as:
- `B1`, `B2`, `B3`, etc.
- To load a new set of information and menu options, reply with: `NEX`

TRS_OUT_3 [2025-04-29 10:33:31 -0400] 878 Bytes | 234 tokens | Cum: 1568 tkns (19.60% of 8k)
==========================================================================

Showing B2 (chunk 1 of 1): B2:
**Zacks Market Edge Highlights: Soundhound AI, Afya, Castle Biosciences, TriMas and Immersion - Zacks Investment Research**Date: Unknown DateSource: Unknown SourceURL: https://www.zacks.com/stock/news/2306053/zacks-market-edge-highlights-soundhound-ai-afya-castle-biosciences-trimas-and-immersionThe article discusses 5 top small-cap stocks that are Zacks Rank #1 (Strong Buy) or #2 (Buy) stocks, including Soundhound AI, Afya, Castle Biosciences, TriMas, and Immersion. The article provides an overview of each company's business, market cap, stock performance, and earnings growth outlook.

Respond with ONLY ONE of the following (3 characters max):
- `MOR` to continue this item
- `NEX` to move to the next set of documents
- `C2`, `S3`, etc. to request another document
**DO NOT SUMMARIZE. DO NOT EXPLAIN.** Wait until all data is presented.

TRS_OUT_5 [2025-04-29 10:33:32 -0400] 789 Bytes | 258 tokens | Cum: 1828 tkns (22.85% of 8k)
==========================================================================

We present this news so you can catch the big movers from recently breaking news.
Here's a list of news articles you can literally read just by asking.
Usually the first item is the most important.

A1 - 2025-04-29T12:14:16Z - TriMas: Q1 Earnings Snapshot...
A2 - 2025-04-29T12:25:19Z - Trimas Non-GAAP EPS of $0.46 beats by $0.06, revenue of $241.7M beats by $6.29M (TRS:NASDAQ)...
A3 - 2025-04-29T12:24:18Z - TriMas Corp. Q1 Profit Increases, Beats Estimates...
A4 - 2025-04-29T12:15:56Z - TriMas: Q1 Earnings Snapshot - WTOP News...
A5 - 2025-04-29T12:15:09Z - TriMas Reports First Quarter 2025 Results...

Request an article by its reference number. (Ex., "A1" gets the first item)
You may also say NEX to go to the next listing.
Response to this prompt limited to 3 chars.

TRS_OUT_7 [2025-04-29 10:33:33 -0400] 1024 Bytes | 289 tokens | Cum: 2119 tkns (26.49% of 8k)
==========================================================================

Showing A1 (chunk 1 of 1): A1:
**TriMas: Q1 Earnings Snapshot**Date: 2025-04-29Source: {'uri': 'sfgate.com', 'dataType': 'news', 'title': 'San Francisco Gate'}URL: https://www.sfgate.com/business/article/trimas-q1-earnings-snapshot-20299934.phpBLOOMFIELD HILLS, Mich. (AP) -- BLOOMFIELD HILLS, Mich. (AP) -- TriMas Corp. (TRS) on Tuesday reported net income of $12.4 million in its first quarter.

The Bloomfield Hills, Michigan-based company said it had net income of 30 cents per share. Earnings, adjusted for non-recurring costs, came to 46 cents per share.

The maker of packaging materials, aerospace components and other engineered parts posted revenue of $241.7 million in the period.

TriMas expects full-year earnings in the range of $1.70 to $1.85 per share.

Respond with ONLY ONE of the following (3 characters max):
- `MOR` to continue this item
- `NEX` to move to the next set of documents
- `C2`, `S3`, etc. to request another document
**DO NOT SUMMARIZE. DO NOT EXPLAIN.** Wait until all data is presented.

TRS_OUT_9 [2025-04-29 10:33:35 -0400] 1114 Bytes | 304 tokens | Cum: 2425 tkns (30.31% of 8k)
==========================================================================

This is our list of SEC filings.
If empty, the search returned no recent filings.

S1 - 2025-04-29 8-K Item 2.02 Results of Oper and Fin Cond.

TriMas Corporation (the Company) issued a press release on April 29, 2025, reporting its financial results for the first quarter ending March 31, 2025. A copy of the press release is attached hereto as Exhibit 99.1 and is...

S2 - 2025-03-31 8-K Item 1.01 Entry into a Material Definitive Agrmt.

Amendment to Existing Credit Agrmt

On March 31, 2025, TriMas Corporation, a Delaware corporation (the Company), TriMas Company LLC, a Delaware limited liability company (the Parent Borrower), and certain other subsidia...

S4 - 2025-03-20 8-K Item 7.01. Regulation FD Disclosure.

On March 20, 2025, the Company issued a press release announcing the resignation of Mr. Mell as Chf Fin Off and the appointment of Ms. Finley as Interim CFO. A copy of the press release is attached hereto as Exhibit 99.1 and inco...

Request filing by its reference number. (Ex., "S1" gets the first item)
You can say NEX to go to the next listing.
Response limited to 3 chars.

TRS_OUT_11 [2025-04-29 10:33:36 -0400] 1067 Bytes | 257 tokens | Cum: 2684 tkns (33.55% of 8k)
==========================================================================

Showing S1 (chunk 1 of 1): S1:
Item 2.02 Results of Operations and Financial Condition.

TriMas Corporation (the Company) issued a press release on April 29, 2025, reporting its financial results for the first quarter ending March 31, 2025. A copy of the press release is attached hereto as Exhibit 99.1 and is incorporated herein by reference. The press release is also available on the Corporation's website at www.trimas.com .

The information presented in Exhibit 99.1 shall not be deemed filed for purposes of Section 18 of the Securities Exchange Act of 1934 (the Exchange Act) or otherwise subject to the liabilities under that Section and shall not be deemed to be incorporated by reference into any filing of the Company under the Securities Act of 1933 (the "Securities Act") or the Exchange Act....

Respond with ONLY ONE of the following (3 characters max):
- `MOR` to continue this item
- `NEX` to move to the next set of documents
- `C2`, `S3`, etc. to request another document
**DO NOT SUMMARIZE. DO NOT EXPLAIN.** Wait until all data is presented.

TRS_OUT_13 [2025-04-29 10:33:48 -0400] 6815 Bytes | 1915 tokens | Cum: 4601 tkns (57.51% of 8k)
==========================================================================

This is our set of metrics for Trimas.
Please analyze the numbers.

+---------------------+-----------------------+-------------------------+-----------------------+
| Volume: 98,484 | Perf Month: -0.26% | Option/Short: Yes / Yes | Sales Y/Y TTM: 3.52% |
+---------------------+-----------------------+-------------------------+-----------------------+
| Avg Volume: 448.90K | Perf Quarter: -5.67% | Short Float: 8.53% | ROE: 3.59% |
+---------------------+-----------------------+-------------------------+-----------------------+
| Rel Volume: 1.31 | Index: RUT | Short Ratio: 6.34 | ROI: 2.20% |
+---------------------+-----------------------+-------------------------+-----------------------+
| RSI (14): 59.93 | Market Cap: 947.47M | Short Interest: 2.85M | Sales Surprise: 2.66% |
+---------------------+-----------------------+-------------------------+-----------------------+
| ATR (14): 1.33 | Shs Outstand: 40.57M | Beta: 0.60 | EPS Surprise: 14.86% |
+---------------------+-----------------------+-------------------------+-----------------------+
| SMA20: 9.28% | Shs Float: 33.37M | Sales Q/Q: 8.82% | P/E: 39.39 |
+---------------------+-----------------------+-------------------------+-----------------------+
| SMA50: 3.36% | Inst Own: 98.17% | Sales past 5Y: 5.09% | Earnings: Apr 29 BMO |
+---------------------+-----------------------+-------------------------+-----------------------+
| SMA200: -5.58% | Insider Own: 18.05% | Employees: 3900 | |
+---------------------+-----------------------+-------------------------+-----------------------+
| Perf Week: 11.93% | Insider Trans: 14.81% | Debt/Eq: 0.66 | |
+---------------------+-----------------------+-------------------------+-----------------------+

The next section covers any insider trading by Trimas officers or majority shareholders (if available).

Inside Trans: TRIMAS CORP (TRS) by Finley Teresa (Interim CFO) on 2025-03-20
- Common Stock: 20000 shares at $0 (D)

Inside Trans: TRIMAS CORP (TRS) by Mell Scott A (Chief Financial Officer) on 2025-03-14
- Common Stock: 22774 shares at $0 (D)
- Common Stock: 1832 shares at $24.15 (D)

Inside Trans: TRIMAS CORP (TRS) by Tredwell Daniel P (Unknown Title) on 2025-03-14
- Common Stock: 4140 shares at $0 (D)

Inside Trans: TRIMAS CORP (TRS) by Finley Teresa (Unknown Title) on 2025-03-14
- Common Stock: 4140 shares at $0 (D)

Inside Trans: TRIMAS CORP (TRS) by Stanage Nick L (Unknown Title) on 2025-03-14
- Common Stock: 4140 shares at $0 (D)

Inside Trans: TRIMAS CORP (TRS) by Boehne Holly M (Unknown Title) on 2025-03-14
- Common Stock: 4140 shares at $0 (D)

Inside Trans: TRIMAS CORP (TRS) by Parker Herbert K (Unknown Title) on 2025-03-14
- Common Stock: 4140 shares at $0 (D)

[Company Financial Summary]
[Company Details]
Name: N/A
Market Cap: N/A
Shares Outstanding: N/A
Sector: N/A

[Financial Statements - Latest Quarter]
Total Assets: N/A
Total Liabilities: N/A
Total Equity: N/A
Revenue (Quarter): {'value': 925010000.0, 'unit': 'USD', 'label': 'Revenues', 'order': 100}
Net Income: {'value': 24250000.0, 'unit': 'USD', 'label': 'Net Income/Loss', 'order': 3200}
Earnings Per Share (EPS): N/A

[Price Metrics - Last 30 Days]
Latest Close: 23.63
Average Volume: 423037.71
30-Day High: 23.63
30-Day Low: 19.9

[Detailed Financials: TTM 2024]
- Total Assets: $1,324,180,000.00
- Total Liabilities: $656,880,000.00
- Total Equity: $667,300,000.00
- Current Assets: $426,640,000.00
- Current Liabilities: $159,430,000.00

[Income Statement: TTM 2024]
- Revenue: $925,010,000.00
- Net Income: $24,250,000.00
- Gross Profit: $199,460,000.00
- Operating Income: $47,190,000.00
- Earnings Per Share (EPS): 0.6

[Cash Flow Statement: TTM 2024]
- Net Cash Flow: $-11,820,000.00

[Detailed Financials: FY 2024]
- Total Assets: $1,324,180,000.00
- Total Liabilities: $656,880,000.00
- Total Equity: $667,300,000.00
- Current Assets: $426,640,000.00
- Current Liabilities: $159,430,000.00

[Income Statement: FY 2024]
- Revenue: $925,010,000.00
- Net Income: $24,250,000.00
- Gross Profit: $199,460,000.00
- Operating Income: $47,190,000.00
- Earnings Per Share (EPS): 0.6

[Cash Flow Statement: FY 2024]
- Net Cash Flow: $-11,820,000.00
==== END OF FINANCIAL REPORT ====

You are now requested to write a summary analysis of Trimas (TRS).

Please complete the report using the exact format:
FIELD[value]

1) BRIEF_SUMMARY[]
One well-worded paragraph summarizing your findings about Trimas.

2) MARKET_SCORE[]
This conversation was initiated because TRS is currently experiencing upward price and volume movement.
Estimate a number between 1–100 based on the likelihood of a continued upward price move for TRS.
Weigh relevant data — news, filings, fundamentals, and metrics — and assign appropriate weight.

3) PRICE_TARGET[]
Suggest a price, based on all prior evidence and past price behavior, TRS could reach in the current or upcoming trading sessions (1–5 days).
For example, if you expect TRS to increase 50% from its current price of $0.00, say: PRICE_TARGET[0.0]

4) AI_RPT_HEADLINE[]
Write a thought-provoking 8–12 word headline summarizing this report.

5) SQUEEZE_POTENTIAL[]
Give a score from 1 to 100 representing the potential for this stock to become an active short squeeze play.
Be honest and unbiased. Consider short interest/float, price movement, volume, news strength, and volatility potential.

6) TAGS[]
List 3–6 comma-separated tags (e.g., biotech, earnings beat, squeeze setup)

7) STOCK_TYPE[]
Choose the most accurate classification: growth, value, turnaround, hype, squeeze, dividend, speculative, or other.

8) PRIMARY_CATALYST[]
e.g., earnings report, FDA approval, partnership, etc.

9) SENTIMENT[]
bullish, bearish, neutral, or mixed

10) IMPROVEMENT_SUGGESTION[]
If you believe some key info was missing, state what would have significantly improved your analysis of Trimas.

11) ETHICAL_RATING[]
Rate Trimas’s alignment with long-term shareholder interests, using a letter grade from A (high alignment) to F (low alignment).
Base this on actions such as insider buying/selling, share dilution, follow-through on public statements, and compensation practices.

12) UPCOMING_CATALYST[]
Specify any upcoming events you expect would be a catalyst affecting the share-price of Trimas.
Provide any reasons you can use to support it.

Return only: FIELD[value] for each of the above 12 questions.
Respond with all data pairs. Take your best guess if you have to, but don't leave blank items.
Do not explain your answers. Return only the required fields in the exact format shown.

Finally, thank you for participating!

TRS_IN_15 [2025-04-29 10:33:48 -0400] 126 Bytes | 29 tokens | Cum: 4836 tkns (60.45% of 8k)
==========================================================================

====================================
[2025-04-29 10:33:48] # Analysis Completed
Elapsed Time: 19.54 seconds